SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001595585-20-000118
Filing Date
2020-08-24
Accepted
2020-08-24 08:41:58
Documents
17
Period of Report
2020-08-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcda-20200821.htm   iXBRL 8-K 47035
2 EX-99.1 fdapdufapressrelease.htm EX-99.1 12936
8 GRAPHIC image011.jpg GRAPHIC 6561
9 GRAPHIC tcda-20200821_g1.jpg GRAPHIC 5018
  Complete submission text file 0001595585-20-000118.txt   233169

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20200821.xsd EX-101.SCH 2433
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcda-20200821_cal.xml EX-101.CAL 720
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcda-20200821_def.xml EX-101.DEF 1657
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20200821_lab.xml EX-101.LAB 25293
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20200821_pre.xml EX-101.PRE 13200
10 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20200821_htm.xml XML 11246
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 201124755
SIC: 2834 Pharmaceutical Preparations